We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery Outcomes Better with Higher BMI

By HospiMedica International staff writers
Posted on 06 Dec 2011
Surgical patients with a body mass index (BMI) at the lower end of the normal range were more likely to die within 30 days of the procedure than those in the moderately overweight range, according to a new study.

Researchers at the University of Virginia (Charlottesville, USA) conducted a multivariable logistic regression analysis of 189,533 surgeries performed in 2005 and 2006, which were recorded in the US National Surgical Quality Improvement Program (NSQIP) database. More...
The researchers wished to assess the statistical significance of the relationship between BMI and mortality, with adjustments for patient-level differences in overall mortality risk and principal operating procedures. A separate multivariable logistic regression model was developed to assess the significance of the interaction between BMI and primary procedure.

The results showed that among 3,245 patients that died within 30 days of their surgery (1.7%), those with a BMI of less than 23.1 demonstrated a significant increased risk of death, with 40% higher odds compared to patients in the middle range for BMI (26.3 to 29.7). Evaluation of 30-day mortality odds ratios for 45 individual types of surgeries--with laparoscopy as the reference--ranged from 0.03 for breast lumpectomy to 2.47 for noncardiac vascular bypass and shunt procedures, before accounting for BMI. The researchers also found that mortality increased linearly to BMI in some procedures, relative to laparoscopy. These included ileostomies and other enterostomies, musculoskeletal procedures, and mastectomies, among other procedures. The study was published in the November 21, 2011, issue of the Archives of Surgery.

“Body mass index is a significant predictor of mortality within 30 days of surgery, even after adjusting for the contribution to mortality risk made by type of surgery and for a specific patient's overall expected risk of death,” concluded lead author George Stukenborg, PhD, and colleagues. “These individual types of procedures include procedures with which the general surgeon should have definite experience; colorectal resection, colostomy formation, cholecystectomy, hernia repair, mastectomy, and wound debridement.”

Related Links:
University of Virginia


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.